These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27103341)

  • 1. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
    Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
    Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates.
    Bogdani M; Speake C; Dufort MJ; Johnson PY; Larmore MJ; Day AJ; Wight TN; Lernmark Å; Greenbaum CJ
    Diabetologia; 2020 Mar; 63(3):549-560. PubMed ID: 31907557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in {beta}-cell proliferation precedes apoptosis during diabetes development in bio-breeding/worcester rat: beneficial role of Exendin-4.
    Pérez-Arana G; Blandino-Rosano M; Prada-Oliveira A; Aguilar-Diosdado M; Segundo C
    Endocrinology; 2010 Jun; 151(6):2538-46. PubMed ID: 20410202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats.
    Weringer EJ; Like AA
    Am J Pathol; 1988 Aug; 132(2):292-303. PubMed ID: 3135758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to fatty acid-induced β-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: a potential link between β-cell lipotoxicity and islet inflammation.
    Tang C; Naassan AE; Chamson-Reig A; Koulajian K; Goh TT; Yoon F; Oprescu AI; Ghanim H; Lewis GF; Dandona P; Donath MY; Ehses JA; Arany E; Giacca A
    Endocrinology; 2013 Jan; 154(1):89-101. PubMed ID: 23150493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.
    Skak K; Gotfredsen CF; Lundsgaard D; Hansen JB; Sturis J; Markholst H
    Diabetes; 2004 Apr; 53(4):1089-95. PubMed ID: 15047626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulitis and mechanisms of disease resistance: studies in an animal model of insulin dependent diabetes mellitus.
    Bone AJ; Hitchcock PR; Gwilliam DJ; Cunningham JM; Barley J
    J Mol Med (Berl); 1999 Jan; 77(1):57-61. PubMed ID: 9930928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet.
    Wang GS; Kauri LM; Patrick C; Bareggi M; Rosenberg L; Scott FW
    J Cell Physiol; 2010 Aug; 224(2):501-8. PubMed ID: 20432450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Wreven E; Ruiz de Adana MS; Hardivillé S; Gmyr V; Kerr-Conte J; Chetboun M; Pasquetti G; Delalleau N; Thévenet J; Coddeville A; Vallejo Herrera MJ; Hinden L; Benavides Espínola IC; Gómez Duro M; Sanchez Salido L; Linares F; Bermúdez-Silva FJ; Tam J; Bonner C; Egan JM; Olveira G; Colomo N; Pattou F; González-Mariscal I
    Diabetologia; 2024 Sep; 67(9):1877-1896. PubMed ID: 38864887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
    Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
    Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered islet homeostasis before classic insulitis in BB rats.
    Wang GS; Karamchandani J; Pulido O; Rosenberg L; Scott FW
    Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S90-7; discussion 3S108-12. PubMed ID: 12688639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
    Irwin N; Pathak V; Pathak NM; Gault VA; Flatt PR
    Diabetes Obes Metab; 2015 Sep; 17(9):887-95. PubMed ID: 26095087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.
    Campbell-Thompson M; Fu A; Kaddis JS; Wasserfall C; Schatz DA; Pugliese A; Atkinson MA
    Diabetes; 2016 Mar; 65(3):719-31. PubMed ID: 26581594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic insulin treatment of syngeneically transplanted pre-diabetic BB-DP rats.
    Sparre T; Sprinkel AM; Christensen UB; Karlsen AE; Pociot F; Nerup J
    Autoimmunity; 2003 Mar; 36(2):99-109. PubMed ID: 12820692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.
    Kiekhaefer CM; Weber B; Huggins M; Gorichanaz C; Nehring JA; DeLuca HF
    Clin Exp Immunol; 2011 Dec; 166(3):325-32. PubMed ID: 22059989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.